Blue Water Acquisition Corp III
BLUW
NASDAQ Global Select10.32
USD
+0.01
- -
Blue Water Acquisition Corp III
BLUW
(NASDAQ Global Select)
Recent
price
10.32
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Blue Water Acquisition Corp. III, a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses, primarily targets high-potential companies in the biotechnology, healthcare, technology, and artificial intelligence sectors; it offers no current operational products or services beyond its SPAC structure, which provides public market access through de-SPAC transactions for private entities in these industries. Founded in 2024 and headquartered at 15 E. Putnam Avenue, Suite 363, Greenwich, Connecticut, the company operates principally in the United States with a global acquisition mandate. In June 2025, it completed an upsized $253 million initial public offering of 25.3 million units at $10 each on Nasdaq under symbols BLUW and BLUWW, fully exercising the underwriters' over-allotment option; in September 2025, it submitted a $10 billion unsolicited bid for PDV Holding Inc., parent of Citgo Petroleum Corp., including a $3.2 billion settlement for defaulted PDVSA 2020 bondholders, though a U.S. court denied its request to extend the sale hearing and it later suspended participation in the process; most recently, on November 25, 2025, it executed a sponsor change via a Purchase Agreement, transferring control to a new sponsor that acquired Class B shares and private units for $7.2 million, resulting in a complete management and board overhaul.
BLUW Stock: 11 Things to Know About Blue Water SPAC Amid Short-Squeeze Rumors
A handful of heavily shorted SPACs are being squeezed higher as investors redeem shares ahead of final merger
Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.
Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Blue Water Acquisition Corp. - BLUW